TSX : CRON.TO
$0.04 (1.03%)
TSX
Michael Ryan Gorenstein
Drug Manufacturers - Specialty & Generic
Healthcare
CRON.TO
610
CA
CAD
0.00
21.87
20.73
19.37
0.00
$149.15M
6.55
0.99
39.49
0.07
-$0.0251
-$9.61M
-1.29%
-4.22%
-0.19%
-0.18%
-1270.69
10.11
10.11
2/5
12 Analysts
%
About Cronos Group Inc. (TSX:CRON.TO) Stock
Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the cultivation, production, and commercialization of cannabis and cannabis-infused products for both medicinal and adult-use sectors. Its comprehensive product offerings encompass dried cannabis flower, pre-rolled joints, edibles, concentrated forms, and cannabis extracts. These are distributed via wholesale partnerships and direct-to-consumer channels, prominently featuring its wellness platform, P ... EACE NATURALS, and its adult-use brand, Spinach. Moreover, Cronos Group exports dried cannabis and cannabis oils to international markets including Germany, Israel, and Australia. Established in 2012, the company maintains its corporate headquarters in Toronto, Canada.
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
2026-06-22 17:30:00
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.
Cronos Group Reports 2026 First Quarter Results
2026-05-11 07:30:00
Net revenue in Q1 2026 increased by 40% year-over-year to $45. 2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS continues to be the number one cannabis brand2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc.
Frequently Asked Questions
What is the current Cronos Group Inc. (CRON.TO) stock price?
Cronos Group Inc.(TSX:CRON.TO) stock price is $3.92 in the last trading session. During the trading session, CRON.TO stock reached the peak price of $4.66 while $2.67 was the lowest point it dropped to. The percentage change in CRON.TO stock occurred in the recent session was 1.03% while the dollar amount for the price change in CRON.TO stock was $0.04.
CRON.TO's industry and sector of operation?
The TSX listed CRON.TO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of CRON.TO?
Arye Weigensberg
| Senior Vice President and Head of Research & Development
Harrison Aaron
| Senior Director of Investor Relations & Corporate Development
Shannon Buggy
| Senior Vice President & Global Head of People
Adam Wagner
| General Manager of Cronos Israel
Jeffrey David Jacobson
| Chief Growth Officer
How many employees does CRON.TO have?
Number of CRON.TO employees currently stands at 610. CRON.TO operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.
Link for CRON.TO official website?
Official Website of CRON.TO is: https://www.thecronosgroup.com
How do I contact CRON.TO?
CRON.TO could be contacted at phone #416-504-0004 and can also be accessed through its website. CRON.TO operates from 111 Peter Street, Stayner, ON M5V 2H1, CA.
How many shares of CRON.TO are traded daily?
The average number of CRON.TO shares traded daily for last 3 months was 183.23K.
What is the market cap of CRON.TO currently?
The market value of CRON.TO currently stands at $1.46B with its latest stock price at $3.92